Organon (OGN) Equity Average (2020 - 2026)

Organon's Equity Average history runs 7 years deep, the most recent figure standing at $827.5 million for Q1 2026.

• In Q1 2026, Equity Average rose 63.21% year-over-year to $827.5 million; the TTM figure through Mar 2026 stood at $827.5 million (up 63.21% YoY), while the FY2025 annual figure was $612.0 million, up 204.48% from the prior year.
• Equity Average was $827.5 million for Q1 2026 at Organon, roughly flat from $829.0 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $829.0 million in Q4 2025 to a low of -$1.4 billion in Q1 2022.
• Historically, Equity Average has averaged -$147.6 million across 5 years, with a median of -$11.0 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Equity Average tumbled 185.62% in 2022, then soared 4709.09% in 2025.
• A 5-year view of Equity Average shows it stood at -$979.0 million in 2022, then soared by 66.34% to -$329.5 million in 2023, then surged by 246.43% to $482.5 million in 2024, then surged by 71.81% to $829.0 million in 2025, then retreated by 0.18% to $827.5 million in 2026.
• The last three Equity Average figures came in at $827.5 million (Q1 2026), $829.0 million (Q4 2025), and $819.5 million (Q3 2025), per Business Quant data.